💻 We are pleased to have reconvened the consortium of the PMed4HB project (pmed4hb.eu), funded by the Spanish Association Against Cancer.
🎯 On this occasion, the team from CIMA University of Navarra presented a new potential therapeutic target for treating hepatoblastoma, with preliminary data showing very promising results.
We are immensely grateful for the continuous support of the Spanish Association Against Cancer, which allows us to continue researching hepatoblastoma, the most common childhood liver cancer.
Comments